RSPKX
Price
$23.57
Change
-$0.91 (-3.72%)
Updated
Dec 18 closing price
VSIAX
Price
$85.23
Change
-$3.35 (-3.78%)
Updated
Dec 18 closing price
Ad is loading...

RSPKX vs VSIAX

Header iconRSPKX vs VSIAX Comparison
Open Charts RSPKX vs VSIAXBanner chart's image
Victory RS Partners R
Price$23.57
Change-$0.91 (-3.72%)
VolumeN/A
CapitalizationN/A
Vanguard Small Cap Value Index Admiral
Price$85.23
Change-$3.35 (-3.78%)
VolumeN/A
CapitalizationN/A
RSPKX vs VSIAX Comparison Chart
Loading...
View a ticker or compare two or three
VS
RSPKX vs. VSIAX commentary
Dec 19, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is RSPKX is a Hold and VSIAX is a Hold.

FUNDAMENTALS
Fundamentals
VSIAX has more cash in the bank: 63B vs. RSPKX (558M). VSIAX pays higher dividends than RSPKX: VSIAX (2.01) vs RSPKX (0.68). RSPKX was incepted earlier than VSIAX: RSPKX (18 years) vs VSIAX (13 years). RSPKX is a more actively managed with annual turnover of: 72.00 vs. VSIAX (16.00). RSPKX has a lower initial minimum investment than VSIAX: RSPKX (0) vs VSIAX (3000). VSIAX annual gain was more profitable for investors over the last year : 16.23 vs. RSPKX (15.19). VSIAX return over 5 years is better than : 52.83 vs. RSPKX (13.92).
RSPKXVSIAXRSPKX / VSIAX
Total Expense RatioN/AN/A-
Annual Report Gross Expense RatioN/AN/A-
Fund Existence18 years13 years-
Gain YTD13.29415.03188%
Front LoadN/AN/A-
Min. Initial Investment03000-
Min. Initial Investment IRAN/AN/A-
Net Assets558M63B1%
Annual Yield % from dividends0.682.0134%
Returns for 1 year15.1916.2394%
Returns for 3 years10.4920.6751%
Returns for 5 years13.9252.8326%
Returns for 10 years-14.51105.65-14%
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
ALTO1.470.04
+2.80%
Alto Ingredients
ADXN7.80-0.05
-0.64%
Addex Therapeutics Ltd
DCOM33.96-0.84
-2.41%
Dime Community Bancshares
CAVA123.37-3.42
-2.70%
CAVA Group
EWTX30.17-2.52
-7.71%
Edgewise Therapeutics